Introduction to Valve Selection

Transcatheter aortic valve implantation (TAVI) significantly helps patients with severe aortic stenosis. Specifically, it improves systolic function in those with reduced left ventricular ejection fraction (LVEF). However, clinicians often debate whether balloon-expandable valves (BEV) or self-expanding valves (SEV) offer better outcomes. Moreover, recent research provides a real-world comparison of these devices for TAVI in LV dysfunction. Therefore, understanding these differences helps optimize patient care in complex cardiovascular cases.

Hemodynamic and Functional Outcomes

The study compared change in ejection fraction between BEV and SEV in adults with LVEF under 50%. Researchers examined procedural success and clinical outcomes to determine which valve type promotes better recovery. Although SEVs typically show hemodynamic advantages, the study found comparable procedural success rates between the two platforms. Consequently, both valve types remain viable options for high-risk patients. Furthermore, both groups demonstrated a significant and similar recovery in left ventricular function over time. In contrast, hemodynamic profiles often favored self-expanding designs due to lower post-procedural transvalvular gradients.

Impact of Valve Selection on TAVI in LV Dysfunction

Clinicians must consider several factors when choosing a valve for TAVI in LV dysfunction. While SEVs provide better hemodynamics in small aortic annuli, BEVs are often associated with lower rates of permanent pacemaker implantation. Additionally, the risk of paravalvular leak is generally lower with newer-generation balloon-expandable devices. Because LVEF recovery is a primary goal, the finding that both valves perform similarly in this regard is reassuring. Ultimately, the choice of valve should depend on the patient's specific anatomy and procedural risks rather than a perceived superiority in functional recovery.

Summary of Findings

Patients with severe aortic stenosis and reduced ejection fraction benefit greatly from intervention. This study confirms that both BEV and SEV lead to improved LVEF. Specifically, the choice between balloon-expandable and self-expandable valves did not drastically alter the long-term systolic recovery. Therefore, operators can select the most appropriate device based on technical requirements and vascular access. Moreover, continued monitoring of these patients is essential to manage potential long-term complications like structural valve deterioration.

Frequently Asked Questions

Which valve is better for TAVI in LV dysfunction?

Current evidence suggests that both balloon-expandable and self-expandable valves provide similar improvements in left ventricular ejection fraction. The choice usually depends on patient anatomy and the risk of conduction disturbances.

Do SEVs offer better hemodynamics than BEVs?

Yes, self-expanding valves (SEVs) generally result in lower transvalvular gradients and larger effective orifice areas compared to balloon-expandable valves, particularly in patients with small aortic annuli.

Is LVEF recovery guaranteed after TAVI?

While most patients see an improvement in systolic function, recovery depends on the underlying cause of dysfunction, such as the presence of myocardial fibrosis or coronary artery disease.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional recommendation. Healthcare professionals should rely on their clinical judgment and the specific needs of their patients. Refer to the latest local and national guidelines for clinical practice.

References

Dababneh E et al. Balloon Versus Self-Expandable TAVI in Patients With Left Ventricular Dysfunction: A Real-World Comparative Study. Catheter Cardiovasc Interv. 2026 Mar 10. doi: 10.1002/ccd.70547. PMID: 41807280.

Matta A et al. Survival outcomes of TAVR and self-expanding versus balloon-expandable valves in patients with advanced cardiac dysfunction. ESC Heart Fail. 2024 Jun;11(3):1452-1462. doi: 10.1002/ehf2.14697.

Kuntic M et al. Prognostic Impact of Left Ventricular Ejection Fraction Improvement after Transcatheter Aortic Valve Replacement. J Clin Med. 2024 Jun 21;13(13):3639. doi: 10.3390/jcm13133639.